China Pharma Holdings (CPHI) Other Non Operating Income (2010 - 2011)
China Pharma Holdings (CPHI) posted Other Non Operating Income of $256762.0 for Q2 2011, down 62.1% on a QoQ basis from $677498.0 in Q1 2011, and down 68.18% year-over-year from $807005.0 in Q2 2010.
China Pharma Holdings (CPHI) Other Non Operating Income (2010 - 2011) Analysis & Trends
China Pharma Holdings' Other Non Operating Income history runs 2 years deep, the most recent figure standing at $256762.0 for Q2 2011.
- Quarterly Other Non Operating Income fell 68.18% year-over-year to $256762.0 in Q2 2011, while the trailing twelve-month figure through Mar 2012 was $256762.0 (down 84.97% YoY) and the FY2011 annual result came in at $934260.0, down 41.2% from the prior year.
- Other Non Operating Income was $256762.0 for Q2 2011 at China Pharma Holdings, down from $677498.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $807005.0 in Q2 2010 and bottomed at -$206308.0 in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2011 | 256,762.00 |
| Mar 31, 2011 | 677,498.00 |
| Dec 31, 2010 | -206,308.00 |
| Sep 30, 2010 | 429,687.00 |
| Jun 30, 2010 | 807,005.00 |